Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Byrne

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Bone Marrow Transplantation|March 27, 2020
Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization InitiativeChloe Anthias, Jane Apperley, Adrian Bloor, et al.
Bone Marrow Transplantation|January 30, 2021
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMTSimone Cesaro, Gloria Tridello, Nina Simone Knelange, et al.
Bone Marrow Transplantation|April 17, 2025
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMTMustafa Güven, Christophe Peczynski, William Boreland, et al.
Leukemia|September 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacyAndrew J Innes, Chloe Hayden, Victoria Orovboni, et al.
Internal Medicine Journal|December 17, 2019
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patientsDaniel Lapirow, Andre La Gerche, Claudia Toro, et al.
Bone Marrow Transplantation|March 7, 2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT studyMalgorzata Mikulska, Gloria Tridello, Per Ljungman, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2023
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized TrialClaire N Harrison, Jyoti Nangalia, Rebecca Boucher, et al.
Leukemia|March 28, 2026
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomesLaura Li Gagnon, Andrea Duminuco, Fabio Stagno, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Bone Marrow Transplantation|March 27, 2020
Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization InitiativeChloe Anthias, Jane Apperley, Adrian Bloor, et al.
Bone Marrow Transplantation|January 30, 2021
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMTSimone Cesaro, Gloria Tridello, Nina Simone Knelange, et al.
Bone Marrow Transplantation|April 17, 2025
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMTMustafa Güven, Christophe Peczynski, William Boreland, et al.
Leukemia|September 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacyAndrew J Innes, Chloe Hayden, Victoria Orovboni, et al.
Internal Medicine Journal|December 17, 2019
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patientsDaniel Lapirow, Andre La Gerche, Claudia Toro, et al.
Bone Marrow Transplantation|March 7, 2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT studyMalgorzata Mikulska, Gloria Tridello, Per Ljungman, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2023
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized TrialClaire N Harrison, Jyoti Nangalia, Rebecca Boucher, et al.
Leukemia|March 28, 2026
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomesLaura Li Gagnon, Andrea Duminuco, Fabio Stagno, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Pageof 5